Back
Bioscience and Bioengineering
Fast-curing silicone ink opens new doors in 3D printing
Researchers at Lawrence Livermore National Laboratory (LLNL) have developed a new method to 3D print sturdy silicone structures that are bigger, taller, thinner and more porous than ever before. The team’s two-part “fast cure” silicone-based ink for direct ink writing mixes just before printing and sets quickly at room temperature, allowing for longer print times,…
LLNL and BioVind achieve diagnostics milestone
Technology designed to aid on-the-field diagnostics for military applications is gaining a wider reach as Lawrence Livermore National Laboratory (LLNL) and BioVind, LLC achieved a milestone in their partnership: the exclusive licensing of LLNL pathogen diagnostics technology focused on oil and gas applications. The technology, called BioID, is a rapid and portable…
Big Ideas Lab highlights potential for medical and research breakthroughs using neural implants
On the latest episode of the Big Ideas Lab podcast, explore the frontier of implantable technology with experts from Lawrence Livermore National Laboratory (LLNL) and the University of California, San Francisco (UCSF). Listen on Apple or Spotify. Neural implants — implantable, flexible electrode arrays capable of recording and stimulating activity in the brain — are…
LLNL researchers discover promising treatment to counteract the effects of fentanyl for overdose cases
A team of Lawrence Livermore National Laboratory (LLNL) researchers has discovered a promising new treatment to counteract the effects of fentanyl and related opioids. The new treatment could, over time, be a boon to doctors and medical professionals dealing with the crisis of fentanyl, a drug whose lethal effects has killed more than 210,000 Americans during the past…
From the battlefield to biocontainment: meet Sean Leonard
Science at Lawrence Livermore National Laboratory (LLNL) is what synthetic biologist and postdoctoral researcher Sean Leonard calls a “team sport.” This is one of the aspects he enjoys the most about working in a national laboratory environment. “I’d say my military experience fundamentally shaped how I approach science,” said Leonard. “In the Army, I learned that I like…
Getting into the details of carbon accounting
Carbon dioxide removal (CDR) is essential for climate change mitigation, but no single standardized methodology exists for evaluating project-level net carbon removal from the atmosphere. Lawrence Livermore National Laboratory (LLNL) scientists and collaborators from Lawrence Berkeley and National Renewable Energy national laboratories and UC Berkeley, have looked into the…
All ears on the Big Ideas Lab podcast
Lawrence Livermore National Laboratory (LLNL) has big ideas and is showing the world in the Big Ideas Lab weekly podcast that takes listeners behind the fences and into its heart. “This is where big ideas come to life,” said Lab Director Kim Budil. “To do this, we bring together dynamic teams of many different disciplines — laser physicists and materials scientists and…
Probing carbon capture, atom-by-atom
A team of scientists at Lawrence Livermore National Laboratory (LLNL) has developed a machine-learning model to gain an atomic-level understanding of CO2 capture in amine-based sorbents. This innovative approach promises to enhance the efficiency of direct air capture (DAC) technologies, which are crucial for reducing the excessive amounts of CO2 already present in the…
Livermore’s research involvement in 23-year-old cold case
When local law enforcement are unable to identify skeletal remains, they may seek out external resources and capabilities like those at Lawrence Livermore National Laboratory’s (LLNL) Center for Accelerator Mass Spectrometry (CAMS). That’s exactly what happened in 2007 when police from Newfoundland, Canada, were six years into an investigation with nothing but dead ends…
Signal and image science community comes together for annual workshop
Nearly 150 members of the signal and image science community recently came together to discuss the latest advances in the field and connect with colleagues, friends and potential collaborators at the 28th annual Center for Advanced Image and Signal Science (CASIS) workshop. Held at the University of California Livermore Collaboration Center (UCLCC) for the first time, the…
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
In a substantial milestone for supercomputing-aided drug design, Lawrence Livermore National Laboratory (LLNL) and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. The development of the new drug — BBO-8520 — is the result of…
Unexpected source of nutrients fuels growth of toxic algae from Lake Erie
Climate change, such as warming and changes in precipitation patterns, affects the frequency and severity of harmful algal blooms (HABs) globally, including those of toxin-producing cyanobacteria that can contaminate drinking water. These nutrient-induced blooms cause worldwide public and ecosystem health concerns. Since the mid-1990s, Lake Erie, the shallowest and warmest…
GUIDE team develops approach to redesign antibodies against viral pandemics
In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving Lawrence Livermore National Laboratory (LLNL) researchers has successfully combined an artificial intelligence (AI)-backed platform with supercomputing to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by…
Mitigating the risk of infection in combat-related injuries
The severely invasive nature of combat trauma creates massive regions of injury, colonization and infection, requiring specialized diagnostic and aggressive therapeutic approaches. Previous reports indicate an estimated occurrence of wound infections in 18%–25% of combat-related injuries. Hindering wound recovery are multidrug-resistant microorganisms, which have been…
LLNL and Precision Neuroscience collaboration aims to develop next-generation neural implants
Lawrence Livermore National Laboratory (LLNL) has joined forces with Precision Neuroscience Corporation (Precision) to advance the technology of neural implants for patients suffering from a variety of neurological disorders, including stroke, spinal cord injury and neurodegenerative diseases such as Lou Gehrig's disease. Under the three-year collaboration, outlined in a…
Microbial research unravels a global nitrogen mystery
Ammonia-oxidizing microorganisms (AOM) use ammonia for energy and account for the annual oxidation of approximately 2.3 trillion kilograms of nitrogen in soil, freshwater, the subsurface and man-made ecosystems. But one major question that has remained unanswered for decades is how different AOM species coexist in the same environment: do they compete for ammonia or…
Using agricultural residues for fuel and chemicals
A Lawrence Livermore National Laboratory (LLNL) scientist is part of a research team shedding new light on how to access the sugars locked up in plant materials in order to convert byproducts into new feedstocks for production of fuels, materials and chemicals. Converting grasses, weeds, wood and other plant residues into sustainable products normally produced using…
Two selected as Graduate Student Research program recipients
Two graduate students have earned Department of Energy (DOE) Office of Science Graduate Student Research (SCGSR) Program awards to perform their doctoral dissertation research at Lawrence Livermore National Laboratory (LLNL). The prestigious award helps cover living expenses and travel for 60 students from universities across the nation. Their proposed research projects…
PLS postdocs excel at the 2023 Research Slam
On Thursday, August 24, a dozen LLNL postdocs presented in the annual Postdoctoral Research Slam, answering the question “Why is my research important?” in only three minutes. Each talk was then evaluated by LLNL leadership, awarding first and second place to PLS postdocs Brandon Zimmerman and Aditya Prajapati, respectively. As a bonus, the attending audience voted on…
LLNL scientists use engineered bone marrow for cancer research and treatment
Osteosarcoma (OS) is the most common primary malignant bone cancer in children and adolescents. While many other cancers now have promising therapeutic advances, treatment options for OS have remained unchanged since the introduction of standard chemotherapeutics and offer less than a 25% five-year survival rate for those with metastatic disease. Now, Lawrence Livermore…
